NTII Neurobiological Technologies (MM)

Neurobiological Technologies, Inc. to Present at The Rodman & Renshaw Techvest 6th Annual Healthcare Conference on October 27, 2004 - Webcast Available to all Interested Investors - RICHMOND, Calif., Oct. 20 /PRNewswire-FirstCall/ -- Neurobiological Technologies, Inc. (NASDAQ:NTII) today announced that its President and Chief Executive Officer, Paul E. Freiman, will present a corporate overview at the Rodman & Renshaw Techvest 6th Annual Healthcare Conference at 3:50 p.m. on October 27, 2004, at the Waldorf Astoria, New York. The presentation will be webcast at: http://www.wallstreetwebcasting.com/webcast/rrshq4/ntii/ Listeners are encouraged to visit the website at least 15 minutes prior to the beginning of the scheduled presentation to register and to download and install any necessary audio software. The presentation will be available for 90 days after the event on the NTII website at: http://www.shareholder.com/ntii/medialist.cfm About Neurobiological Technologies, Inc. Neurobiological Technologies, Inc. is a biotechnology company engaged in the business of acquiring and developing central nervous system (CNS) related drug candidates. The company is focused on therapies for neurological conditions that occur in connection with dementia, Alzheimer's disease, ischemic stroke, neuropathic pain, and brain cancer. DATASOURCE: Neurobiological Technologies, Inc. CONTACT: Paul E. Freiman, President & CEO of Neurobiological Technologies, Inc., +1-510-262-1730; Cheryl Schneider, VP - Investor Relations, or Jeff Myhre, VP - Editorial, both of Porter, Le Vay & Rose, Inc. +1-212-564-4700, for Neurobiological Technologies, Inc. Web site: http://www.ntii.com/

Copyright